Buprenorphine Misuse: What's the Reality? New study highlights need to expand access to buprenorphine for OUD Nov 18, 2021
Paramedic Treatment of Status Epilepticus Rarely Consistent With Guidelines Of more than 9,000 EMS encounters, only 3.9% followed expert recommendations Nov 17, 2021
This Behavior on Digital Devices Is Linked to Worse Mental Health in Children Good news for video gamers, however Nov 17, 2021
Early Parkinson's Treatment: AAN Issues New Guidelines Levodopa usually is best first therapy for motor symptoms, neurology group says Nov 15, 2021
Aspirin Flops Again for Dementia Prevention ASCEND trial sides with ASPREE, but can't rule out some potential benefit Nov 15, 2021
Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementia GIRAF trial tested warfarin versus dabigatran in older Afib patients Nov 14, 2021
No Long-Term Cognitive Benefit in Fortified Baby Formulas Commercial claims and policies built on misleading evidence, researchers say Nov 10, 2021
Hypothalamic Gliosis Associated With Obesity in Kids? Use of imaging studies could impact how childhood obesity is prevented and treated Nov 09, 2021
Alzheimer's Plasma Exchange; Fish Intake and Brain Health; HIV Neuropathy News and commentary from the world of neurology and neuroscience Nov 09, 2021
One Aducanumab Patient, Six Brain Edema Episodes "Uniquely complicated course" for patient treated with new Alzheimer's drug Nov 08, 2021
Is LAA Closure With Amulet Less Leaky? Two studies, IDE and SWISS-APERO, come to disparate conclusions Nov 07, 2021
LAA Closure Holds Up Against NOACs Longer-term follow-up from the PRAGUE-17 trial reassures Nov 05, 2021
Prescription Pain Killers Can Be a Slippery Slope We can prevent patients from falling down the rabbit hole Nov 05, 2021
Focused Ultrasound Approved for Advanced Parkinson's Expanded indication includes medication-refractory PD patients with motor problems Nov 05, 2021
Worse COVID-19 Outcomes for Disabled MS Patients But monoclonal antibodies offer hope for high-risk people, registry data show Nov 02, 2021
MS Treatment: Early Aggressive or Escalation Therapy? Clinical trial, observational data may not be enough to decide best strategy Nov 01, 2021
Migraine Drug Shows Benefit for Those With Comorbid Depression, Anxiety Real-world study of fremanezumab found that patients were able to reduce antidepressant use Nov 01, 2021
Guillain-Barre Risk Up Slightly After Shingrix Findings support FDA warning for recombinant zoster vaccine Nov 01, 2021
Michigan EDs See Jump in Cannabis-Related Neuropsychiatric Toxicity Community-based study reports "troublesome" data in state that legalized marijuana for adults Oct 30, 2021
Head Trauma Guidelines Often Abandoned for Young Patients in the ED "There's a lot of room for improvement," researcher says Oct 29, 2021
New MS Drug Does Not Appear to Increase COVID Severity Most COVID cases were mild or moderate in patients treated with ofatumumab Oct 29, 2021
Cannabis Use Common Among People With MS Most don't ask for medical guidance, survey shows Oct 28, 2021
Alan Jackson's Neurological Disorder Country legend announces he's living with Charcot-Marie-Tooth disease Oct 26, 2021
Sudden Psychosis, Abnormal CSF in Three Teens With COVID In two cases, patients responded to immunotherapy Oct 25, 2021
Artificial Intelligence in Psychiatry Has Promise and Peril It may help in assessing things like suicide risk, but its use raises informed consent issues Oct 24, 2021
How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
Ivermectin for COVID-19 Linked to Severe Toxicity in Small Study Confusion, ataxia, seizures, hypotension -- and for some, ICU admission Oct 20, 2021
Frequent MRI May Spot Active Secondary Progressive MS More Quickly "If you rely on having a clinical relapse, you may wait a long time" Oct 19, 2021
Tread Carefully in Choosing the Next FDA Leader The potential re-appointment of Robert Califf as commissioner is cause for concern Oct 19, 2021
HCQ and MS; Guillain-Barre and COVID Vax; Neural Fingerprints Can Tell Who You Are News and commentary from the world of neurology and neuroscience Oct 19, 2021
COVID Vaccine Response Varies With MS Treatment Type How this relates to infection outcomes or risk of infecting others is unknown Oct 18, 2021
Quitting Smoking Tied to Slower Motor Decline in Multiple Sclerosis Analysis suggests smoking cessation has benefits in MS Oct 17, 2021
Slowly Expanding Lesions in MS Reduced With BTK Inhibitor Evobrutinib shows effect on marker of chronic inflammation Oct 17, 2021
Virtual Care May Help Multiple Sclerosis Patients Even After the Pandemic Early study paves the way to look at how telehealth may fit into MS care Oct 15, 2021
Novel Anti-CD20 Drug Shows Promise in Relapsing MS Ublituximab bests teriflunomide in head-to-head phase III trials Oct 14, 2021
Hospital Policy Slashes IV Acetaminophen Use for Tonsillectomy Standing orders for oral use led to better care, reduced cost, researchers said Oct 12, 2021
Warning on Tylenol in Pregnancy No Cause for Alarm More research is needed, but the review should not alter clinical decision-making, experts say Oct 11, 2021
